MedTrace Logo

DB RCT for Specialized Phototherapy in Parkinson's Disease.

NCT04453033 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 350

Last updated 2025-11-13

No results posted yet for this study

Summary

This is a pivotal study to determine whether light therapy can improve non-motor and motor function in Parkinson's disease, on top of current best medical treatment.

Conditions

  • Parkinson Disease

Interventions

DEVICE

Celeste Specialized Phototherapy Device

Ocular phototherapy light panel

Sponsors & Collaborators

  • University of Rochester

    collaborator OTHER

  • PhotoPharmics, Inc.

    lead INDUSTRY

Principal Investigators

  • Ray Dorsey, MD · University of Rochester

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-26
Primary Completion
2026-06-30
Completion
2026-08-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04453033 on ClinicalTrials.gov